Pharmacokinetics of LBPT and its primary metabolites, as well as tolerability in the first‐in‐human study
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Pharmaceutical Sciences"
DOI: 10.1016/j.ejps.2016.12.038
Abstract: Background: LBPT is a novel platelet‐activating factor (PAF) receptor antagonist that is developed for the treatment of rheumatoid arthritis. The purpose of this first‐in‐human study was to evaluate the tolerability and safety of LBPT, to… read more here.
Keywords: primary metabolites; pharmacokinetics lbpt; study; human study ... See more keywords